Back to Iris Pharma home page

Home  |  Contact  |  Sitemap    |  Restricted area  

Ocular Angiogenesis

Ocular Neurodegeneration

Ocular Hypertension

Ocular Allergy

Ocular Inflammation

Ocular Pain

Ocular infection

Corneal wound healing

Diabetic retinopathy

Ocular edema

Ocular Angiogenesis

Models :

  • CORNEAL angiogenesis: sutures or alkali burn
  • RETINAL angiogenesis / retinopathy of prematurity (ROP): animal model of oxygen-induced retinopathy (OIR)
  • CHOROIDAL neovascularization: experimental argon laser-induced CNV (choroidal neovascularization)
  • RETINAL VASCULAR permeability: VEGF-induced fluorescein leakage

Administration : topical ocular application, intraperitoneal injection, subcutaneous application, intravitreous injection, per os

 

Animals : albino or pigmented rabbits, rats, mice

 

Evaluation :

  • length of new vessels
  • fluorescein permeation (fluorotron )
  • angiography (HRA)
  • histology: number of new vessels, retina examination (fundus, HRT), corneal examination (HRT), visualization and quantification of morphologic changes in the CNV model (flatmount evaluation)…

Control substance : Dexamethasone

 

If you need more information on Iris Pharma’s animal models of ocular angiogenesis, please contact us at info@iris-pharma.com or call 33 4 93 59 49 59

 

 

IRIS Pharma